BioCryst Pharmaceuticals, Inc. (BCRX) Free Cash Flow
BioCryst Pharmaceuticals, Inc. (BCRX) free cash flow history and trends. Track FCF in Excel with MarketXLS.
Free Cash Flow Data
| Period | Free Cash Flow (USD) |
|---|---|
| 2016-12-31 | -$28.20M |
| 2017-12-31 | -$41.46M |
| 2018-12-31 | -$92.93M |
| 2019-12-31 | -$89.93M |
| 2020-12-31 | -$135.62M |
| 2021-12-31 | -$144.54M |
| 2022-12-31 | -$163.20M |
| 2023-12-31 | -$97.31M |
| 2024-12-31 | -$53.14M |
| 2025-12-31 | $344.90M |
How BCRX compares with sector peers
| Symbol | Company | Free cash flow (latest fiscal year) |
|---|---|---|
| OGN | Organon & Co. | $414.00M |
| BIO | Bio-Rad Laboratories Inc. Class A | $374.60M |
| PODD | Insulet Corporation | $349.90M |
| HAE | Haemonetics Corporation | $260.44M |
| NVST | Envista Holdings Corporation | $230.40M |
These are five companies in the same sector as BCRX with a comparable annual free cash flow. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get BioCryst Pharmaceuticals, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Free_Cash_Flow("BCRX", 2025, "")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | BCRX | $8.59 | +3.56% | 0.66M |
| 3 | ||||
| 4 | ||||
| 5 |